Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Celcuity Stock Popped on Monday

TheMotleyFool

0 0

Why Celcuity Stock Popped on MondayPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

One of the livelier biotech stocks on the market Monday was Celcuity (NASDAQ: CELC), which saw its share price leap nearly 4% higher thanks to the initiation of coverage by an analyst. That initial report on the company was quite bullish, hence the positive investor reaction.

Well before market open, Citizens pundit Silvan Turkcan launched his tracking of Celcuity stock. He rates the clinical-stage biotech a market outperform (i.e., buy) and has set a $150-per-share price target. That's nearly 20% above the company's latest closing level and is one of the higher price targets among analysts following Celcuity.

Image source: Getty Images.

Source Fool.com

Like: 0

CELC

Share